Age as a prognostic factor in the malignant melanoma population.
about
Optimising surgical management of elderly cancer patients.Clinicopathologic characteristics and management trends of cutaneous invasive and in situ melanoma in older patients: a retrospective analysis of the National Cancer Data BaseMelanoma epidemiology, biology and prognosis.Age as a predictor of sentinel node metastasis among patients with localized melanoma: an inverse correlation of melanoma mortality and incidence of sentinel node metastasis among young and old patients.Malignant melanoma: clinical variants and prognostic indicators.Detection of melanoma nodal metastases; differences in detection between elderly and younger patients do not affect survival.Cutaneous melanoma: prognostic factors.Association of socioeconomic status with Breslow thickness and disease-free and overall survival in stage I-II primary cutaneous melanoma.Demographic and other characteristics of nodal non-Hodgkin's lymphoma managed in academic versus non-academic centersBreslow thickness in the Netherlands: a population-based study of 40 880 patients comparing young and elderly patients.Distance to diagnosing provider as a measure of access for patients with melanoma.Trends in the diagnosis and clinical features of melanoma in situ (MIS) in US men and women: A prospective, observational studyImpact of age on the management of primary melanoma patients.Marital status and stage at diagnosis of cutaneous melanoma: results from the Surveillance Epidemiology and End Results (SEER) program, 1973-2006.Sarcopenia as a prognostic factor among patients with stage III melanoma.Novel Therapies for Metastatic Melanoma: An Update on Their Use in Older Patients.Patterns and Timing of Initial Relapse in Pathologic Stage II Melanoma Patients.Responses to immune checkpoint inhibitors in nonagenarians.Older Age is Associated with a Higher Incidence of Melanoma Death but a Lower Incidence of Sentinel Lymph Node Metastasis in the SEER Databases (2003-2011).Is Age ≥ 70 Years an Important Predictor of Adverse Events Among Patients Enrolled in Metastatic Melanoma Trials? Findings from Pooled Analyses of Therapeutic Trials.Recent advances in the care of the patient with malignant melanoma.Increasing Age Is Associated with Worse Prognostic Factors and Increased Distant Recurrences despite Fewer Sentinel Lymph Node Positives in Melanoma.Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression.Author's reply to: Prognosis of sentinel lymph node biopsy in patients with thick melanoma by a propensity score matching prospective study.Analysis of histopathological factors associated with prolonged survival of 10 years or more for patients with thick melanomas (> 5 mm).Factors associated with melanoma incidence and prognosis.Malignant melanoma: factors affecting the surgical interval from excision biopsy to definitive surgical management.Prognostic evaluation of cutaneous malignant melanoma: a clinicopathologic and immunohistochemical study.
P2860
Q24796933-26044353-F787-4ADC-BFC8-A9BC7B65A93CQ30882472-33F8930C-A6C2-4926-94E9-AB856C5A5204Q33698718-9C6C9719-B628-476C-998E-3FC7F85A9E45Q34000266-E04A0D91-F82B-489D-8585-301C31372DD8Q34067612-E0E4424E-50A4-4455-BE9A-9E149AF2DD29Q34180205-A1BE970C-725E-4D87-9C4B-44507A1CFAD2Q34463933-48729119-1712-431C-B8CA-47E4A18AA4DBQ34541868-FFFD9C37-D14C-4054-830D-DC93AF995951Q36017899-AED807BE-A74C-4670-BFF0-4C28D9ACE8F3Q36117152-1041A95F-E2DD-4630-BBA9-D5AD46A4B500Q36776238-62B544B8-5171-4200-8E99-5C3989026A81Q37270518-0C4E356F-07C5-4FA7-A573-C8A5ACE8148FQ37346993-14064376-DF9F-4A6F-A19F-C781E5056552Q37595347-CB793180-89A1-4931-99C9-84920BAEB0D4Q37913089-F6F88DF2-C10A-408D-BA0E-BA9F7538B756Q38600760-29562A0F-D713-4C23-968D-DAC85F4CBD27Q38996391-49146194-026B-461D-8892-DF136AF54A0DQ39079683-BED6BE25-29B5-4649-B9C0-EA082078598DQ40977287-4113C0CB-1E13-4A1E-821D-B4A23F090CD7Q41113378-5E6D534A-D778-469C-98CF-0983A69BBA9CQ41317571-60B27445-2A47-4E4E-AB03-7CF9424ED4FEQ42560491-53E6C91F-778E-4674-9D9C-81021D79D430Q45201798-F94B0D69-EF45-4B5E-A7D4-D30E546A215BQ48274531-1ACDB878-60EA-414F-93BD-90EEEE01AB3EQ50854697-BF13D0DF-6914-4687-81E7-0C32B82CB563Q50993159-0D2A0131-2A8D-41E6-8F8D-140BE4140845Q51134957-73EBF85F-BB79-4FF8-AB43-5421A5404B4CQ53934608-12A08B22-0209-4F52-8511-7BB70756A8A0
P2860
Age as a prognostic factor in the malignant melanoma population.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Age as a prognostic factor in the malignant melanoma population.
@en
type
label
Age as a prognostic factor in the malignant melanoma population.
@en
prefLabel
Age as a prognostic factor in the malignant melanoma population.
@en
P2093
P356
P1476
Age as a prognostic factor in the malignant melanoma population.
@en
P2093
P2888
P304
P356
10.1007/BF02303614
P577
1994-11-01T00:00:00Z